This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03829/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03829/identifier/pubchem-compound/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03829/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03829/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03829
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03829 n12:DB03829
dcterms:title
Pseudouridine-5'-Monophosphate
adms:identifier
n8:DB03829 n9:46505814 n10:PSU n11:46936800
n3:IUPAC-Name
n4:271B465F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4665-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4664-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4661-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4662-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4663-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B465D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B465E-363D-11E5-9242-09173F13E4C5 n4:271B465B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B465C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B466B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B466C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4666-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4667-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4669-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4668-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B466A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4671-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4673-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4674-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4670-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B466F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4672-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4660-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B466D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B466E-363D-11E5-9242-09173F13E4C5